↑up: Improves executive functionSMD 0.54, 95% CrI 0.35, 0.73 | Review of trials | 8,130 people pooled≥60 yearsOlder adults; in healthy older adults (≥60 years) | Maturitas, Sep 3, 2026 |
↑up: Increases SNS indexβ = 1.79, 95% CI [1.24, 2.33] ↓down: Decreases SNS indexβ = -1.77, 95% CI [-2.52, -1.03] ↔no change: Has no effect on SDNN | Trial24 weeks | 44 people29 women, 15 menmean age 69.7 ± 5.30 yearsCommunity-dwelling older adults | Frontiers in physiology, Aug 28, 2026 |
↓down: Decreases anxiety symptomsSMD -0.62, 95% CI -0.88, -0.36 ↓down: Decreases depressive symptomsSMD -0.68, 95% CI -1.03, -0.34 | Review of trials12 to 48 weeks | 2,298 people pooledwomenranged from approximately 50 to 80 yearsPostmenopausal women | Frontiers in psychiatry, Aug 12, 2026 |
↔no change: Has no effect on C-reactive proteinSMD = −0.24, 95% CrI: −0.91 to 0.42 | Review of trials6 weeks to 12 months | 2,836 people pooledmean age of 76.98 yearsPredominantly older adults with chronic disease, with the remainder comprising healthy older adults and populations with mixed or unspecified health status | Frontiers in medicine, Aug 6, 2026 |
↓down: Decreases sitting timeβ = −0.71, 95% CI −2.07 to 0.52 ↑up: Increases physical activityβ = 0.52, 95% CI −0.76 to 1.81 ↑up: Increases empathyβ = 0.59, 95% CI −0.75 to 1.94 | Trial24 weeks | 44 people29 female and 15 male individualsmean age of 69.7 ± 5.3 yearsCommunity-dwelling older adults | Frontiers in public health, Jan 13, 2026 |
↑up: Improves cognitive functionMoCA Δ = 2.04, p < .01 ↑up: Improves physical functionchair stand Δ = 5.93; arm curl Δ = 5.17; up-and-go Δ = -0.73 s ↔no change: Has no effect on body mass index | Randomized trial12 weeks | ≥60 yearsOlder adults; older adults with mild cognitive impairment | Journal of aging and physical activity, Jan 1, 2026 |